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Usher syndrome is a deafness-blindness disorder. The blindness occurs from a progressive retinal degeneration that begins after deaf-
ness and after the retina has developed. Three clinical subtypes of Usher syndrome have been identiﬁed, with mutations in any one of six
diﬀerent genes giving rise to type 1, in any one of three diﬀerent genes to type 2, and in one identiﬁed gene causing Usher type 3. Mutant
mice for most of the genes have been studied; while they have clear inner ear defects, retinal phenotypes are relatively mild and have been
diﬃcult to characterize. The retinal functions of the Usher proteins are still largely unknown. Protein binding studies have suggested
many interactions among the proteins, and a model of interaction among all the proteins in the photoreceptor synapse has been pro-
posed. However this model is not supported by localization data from some laboratories, or the indication of any synaptic phenotype
in mutant mice. An earlier suggestion, based on patient pathologies, of Usher protein function in the photoreceptor cilium continues to
gain support from immunolocalization and mutant mouse studies, which are consistent with Usher protein interaction in the photore-
ceptor ciliary/periciliary region. So far, the most characterized Usher protein is myosin VIIa. It is present in the apical RPE and pho-
toreceptor ciliary/periciliary region, where it is required for organelle transport and clearance of opsin from the connecting cilium,
respectively. Usher syndrome is amenable to gene replacement therapy, but also has some speciﬁc challenges. Progress in this treatment
approach has been achieved by correction of mutant phenotypes in Myo7a-null mouse retinas, following lentiviral delivery of MYO7A.
 2007 Elsevier Ltd. All rights reserved.
Keywords: Usher syndrome; Mouse; Retina; Cilium1. Clinical subtypes and genetics of Usher syndrome
Retinitis pigmentosa in combination with deafness was
reported 150 years ago (Leibreich, 1861; von Graefe,
1858), and became known as Usher syndrome, as a result
of a report by Charles Usher in 1914 (Usher, 1914). Usher
syndrome is inherited in an autosomal recessive manner
(Usher, 1914), and is responsible for over half of the cases
involving deafness and blindness (Vernon, 1969). It aﬀects
about 1 in 23,000 in the U.S. (Boughman, Vernon, & Sha-
ver, 1983), 1 in 29,000 in Scandinavia and 1 in 12,500 in
Germany (Otterstedde, Spandau, Blankenagel, Kimber-
ling, & Reisser, 2001). Since the frequency of retinitis pig-
mentosa is 1 per 4000 persons (Berson, 1993), Usher0042-6989/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2007.08.015
E-mail address: dswilliams@ucsd.edusyndrome accounts for about 17% of all cases of RP in
the US.
Usher syndrome is clinically and genetically heteroge-
neous. Three clinical subtypes, which are distinguished
from each other primarily by the extent and onset of the
deafness, have been deﬁned (Smith et al., 1994). Usher type
1 patients are profoundly deaf from birth, and have vestib-
ular dysfunction, which results in retarded motor develop-
ment. The deafness in Usher 2 is less severe, and vestibular
function has been described as normal. Usher 3 patients
also have milder deafness, but, unlike in Usher 2, the hear-
ing loss is progressive, and about half have vestibular dys-
function (Sadeghi, Cohn, Kimberling, Tranebjaerg, &
Moller, 2005). RP, which is clinically similar to nonsyndro-
mic retinitis pigmentosa, develops in all types of Usher syn-
drome (Fishman, Kumar, Joseph, Torok, & Anderson,
1983; Smith et al., 1994).
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in any one of six diﬀerent genes, and mutations in any one
of three diﬀerent genes can result in Usher 2. Only one gene
has been identiﬁed for Usher 3. Usher 1 and 2 are the most
common forms of Usher syndrome, with Usher 3 contrib-
uting to a large proportion of cases only in isolated areas,
such as Finland (Pakarinen, Tuppurainen, Laippala,
Mantyjarvi, & Puhakka, 1996) and Birmingham, UK
(Hope, Bundey, Proops, & Fielder, 1997). In some cases,
mutations in these genes do not give rise to both blindness
and deafness. Cases of nonsyndromic deafness have been
linked to mutations in the Usher 1B, 1C, 1D, 1F and 2D
genes (Ahmed et al., 2002; Bork et al., 2001; Liu et al.,
1997b,c; Mburu et al., 2003; Weil et al., 1997). Conversely,
mutations in the Usher 2A and 3 genes can cause autoso-
mal recessive RP without reported hearing loss (Rivolta,
Sweklo, Berson, & Dryja, 2000; Seyedahmadi, Berson, &
Dryja, 2004a; Seyedahmadi, Rivolta, Keene, Berson, &
Dryja, 2004b).
2. Animal models of Usher syndrome
Many of the mouse models for Usher syndrome were
identiﬁed by early mouse geneticists due to their character-
istic circling and head-tossing behavior that results from
vestibular dysfunction. They were given various names that
describe this aberrant behavior. Thus, shaker1 (sh1), deaf
circler (dfcr), waltzer (v), Ames waltzer (av), and Jackson
shaker (js) mice have mutations in genes that are homolo-
gous to the Usher 1 genes, 1B, 1C, 1D, 1F, and 1G, respec-
tively (Alagramam et al., 2001a; Di Palma et al., 2001;
Gibson et al., 1995; Johnson et al., 2003; Kikkawa et al.,
2003). Ush2a knockout mice do not exhibit this behavior
(Liu et al., 2007), which is consistent with normal vestibu-
lar function generally found in Usher 2 patients. Interest-
ingly, whirler (wi) mice, the model for Usher 2D, do runTable 1
Usher syndrome genes and proteins
Subtype Gene Protein (functiona
Usher 1B MYO7A Myosin VIIa (acti
Usher 1C USH1C Harmonin (PDZ-
Usher 1D CDH23 Cadherin23 (adhe
Usher 1E Unknown
Usher 1F PCDH15 Protocadherin15 (
Usher 1G USH1G Sans (scaﬀold)
Usher 2A USH2A Usherin (transmem
Usher 2C GPR98 VLGR1 (G-prote
Usher 2D DFNB31 Whirlin (PDZ-dom
Usher 3 CLRN1 Clarin (synaptic s
References: Usher 1B, (Gibson et al., 1995; Ernest et al., 2000; Kimberling et
Verpy et al., 2000); 1D, (Bolz et al., 2001; Bork et al., 2001; Di Palma et al., 2
(Ahmed et al., 2001; Alagramam et al., 2001a; Alagramam et al., 2001b; Seiler
2003); 2A, (Eudy et al., 1998a; Eudy et al., 1998b; Liu et al., 2007); 2C, (Mc
(Ebermann et al., 2007; Mburu et al., 2003); 3 (Adato et al., 2002; Sankila et al
et al., 1992) has now been shown to be false (Gerber et al., 2006), and a pr
subsequently veriﬁed.
a Some of the indicated functions have not been demonstrated and are merein circles (as their name indicates) and toss their heads
about (Lane, 1963), suggesting that some Usher 2 patients
may indeed possess vestibular dysfunction.
Despite a relatively faithful manifestation of the hearing
and balance disorders found in Usher syndrome, these mice
do not possess severe mutant phenotypes in their retinas.
None of the Usher 1 mouse models undergo retinal degen-
eration. Some evidence of slight degeneration was noted in
the periphery of dfcr retinas (Johnson et al., 2003); how-
ever, none was observed in an examination of animals in
excess of one year old, raised under a controlled light/dark
cycle (C. Lillo and D.S. Williams, unpublished observa-
tions). Mice expressing mutant Gpr98, lacking the trans-
membrane and cytoplasmic domains (Vlgr1/del7TM),
also have normal retinal histology (McGee et al., 2006).
A small loss of photoreceptor cells was measured in old
double shaker1/waltzer mutant mice (Lillo et al., 2003),
but the only Usher mouse model that has so far been
reported to possess any convincing retinal degeneration is
the Ush2a knockout mouse. Individuals have normal pho-
toreceptor morphology and numbers at 10 months of age,
but by 20 months over half the photoreceptor cells have
been lost (Liu et al., 2007).
Of the mice that show no retinal degeneration, reduced
electroretinogram amplitudes have been reported for some
of the alleles of shaker1, waltzer and Ames waltzer mice
(Haywood-Watson et al., 2006; Libby, Kitamoto, Holme,
Williams, & Steel, 2003; Libby & Steel, 2001), as well as
Gpr98-mutant mice (McGee et al., 2006) and knock-in mice
expressing the Acadian USH1C mutant gene (Lentz, Pan,
Ng, Deininger, & Keats, 2007a; Lentz et al., 2007b). At
least in the shaker1, waltzer and Ames waltzer mice the
a- and b-wave amplitudes were reduced by a similar pro-
portion, indicating the defect lay within the photoreceptor
cell response. Additional mutant retinal phenotypes have
been described for the shaker1 mice. These mice possess) Animal models mouse (zebraﬁsh)
n motor) Shaker1 (mariner)
domain protein) Deaf circler
sion protein) Waltzer (sputnik)
adhesion protein) Ames waltzer (orbiter, Pcdh15a)
Jackson shaker
brane linkage) Knockout
in coupled receptor) Vlgr1/del7TM
ain protein) Whirler
haping) None reported
al., 1992; Weil et al., 1995;); 1C, (Johnson et al., 2003; Smith et al., 1992;
001; Sollner et al., 2004; Wayne et al., 1996); 1E, (Chaib et al., 1997); 1F,
et al., 2005); 1G, (Kikkawa et al., 2003; Mustapha et al., 2002; Weil et al.,
Millan & White, 2004; Pieke-Dahl et al., 2000; Weston et al., 2004); 2D,
., 1995). A previously reported locus for Usher syndrome type 1A (Kaplan
eviously reported locus for Usher 2B (Hmani et al., 1999) has not been
ly speculations based on primary sequence.
D.S. Williams / Vision Research 48 (2008) 433–441 435increased opsin concentration in the photoreceptor con-
necting cilium (Liu, Udovichenko, Brown, Steel, & Wil-
liams, 1999), aberrant RPE1 melanosome localization and
motility (Gibbs et al., 2004; Liu, Ondek, & Williams,
1998), and defective phagosome localization and digestion
(Gibbs, Kitamoto, & Williams, 2003), consistent with mul-
tiple roles for myosin VIIa in the retina (see below).
There are now a number of zebraﬁsh models with
mutant or knocked down genes that represent Usher ortho-
logues.Mariner expresses mutantMyo7a, and, like shaker1
mice, exhibits circling behavior and possesses sensory hair
cells with morphological and functional defects (Ernest
et al., 2000). In mariner retinas, the apical localization of
RPE melanosomes has been reported to be defective (Bie-
hlmaier, Hodel, & Neuhaus, 2007), comparable to that in
shaker1 retinas (Liu et al., 1998). A distinction is that, in
many ﬁsh, including zebraﬁsh, the apical migration of
RPE melanosome has a signiﬁcant impact on light adapta-
tion (Burnside, 2001), so that in mariner this defect may be
functionally more relevant (Biehlmaier et al., 2007). Zebra-
ﬁsh have two orthologues of the Usher 1F gene, with orbi-
ter having mutant Pcdh15a. Mutation and knock down
studies have shown that Pcdh15a is required for normal
auditory and vestibular function, and Pcdh15b is required
for normal photoreceptor outer segment organization
and retinal function (Seiler et al., 2005). Sputnik zebraﬁsh
express mutant Cdh23, and have reduced or absent mecha-
notransduction (Nicolson et al., 1998; Seiler & Nicolson,
1999; Sollner et al., 2004), although there are not reports
on their vision. Morphilino knock down studies of the
Usher 1C, 2A and 2C orthologues result in swimming
and balance defects in larvae, similar to those observed in
mariner, and reduced visual function with increased photo-
receptor cell death (Phillips, Chiem, & Westerﬁeld, 2007).
The utility of these zebraﬁsh models for retinal studies
related to Usher syndrome is unclear at present. Some of
the orthologous genes possess regions that are not well con-
served with the Usher genes, so that their proteins may not
have the same function (e.g. Gibert et al., 2005). However,
there appear to be at least some overlapping functions (e.g.
the role of myosin VIIa in RPE melanosome localization),
and the presence of photoreceptor cell death in the zebra-
ﬁsh models provides an important similarity to the human
condition, which is lacking in most of the mouse models.3. Functions of Usher proteins in the retina
The proteins encoded by the known Usher genes are
listed in Table 1. MYO7A was predicted to encode an
unconventional myosin; i.e. a molecular motor that uses
energy from ATP hydrolysis to move along actin ﬁlaments.
Direct experiments have now demonstrated that myosin
VIIa is a bona ﬁde actin-based motor (Inoue & Ikebe,
2003; Udovichenko, Gibbs, & Williams, 2002). The1 Abbreviations: RPE, retinal pigment epithelium.USH1C gene generates a number of diﬀerent isoforms,
belonging to three diﬀerent classes of harmonin. The iso-
forms each contain two or three PDZ domains, so that har-
monin is predicted to be a scaﬀolding protein (Verpy et al.,
2000). The Usher 1D and 1F genes are both predicted to
encode cadherins (Ahmed et al., 2001; Alagramam et al.,
2001b; Bolz et al., 2001; Bork et al., 2001). The Usher
1G protein, sans, is another putative scaﬀolding protein
(Weil et al., 2003). Usherin, encoded by USH2A, was
reported to be an extracellular matrix protein that binds
type IV collagen (Bhattacharya, Kalluri, Orten, Kimber-
ling, & Cosgrove, 2004), however, more recently, a longer
variant of usherin, an exceptionally large protein of 600
kD, with a membrane anchor and short cytoplasmic,
PDZ-binding motif, has been detected in photoreceptor
cells (Liu et al., 2007). VLGR1 appears to be a G-protein
coupled receptor with a large N-terminal region (Weston,
Luijendijk, Humphrey, Moller, & Kimberling, 2004).
Whirlin is another PDZ-domain protein and potential scaf-
fold (Mburu et al., 2003). Lastly, the only reported Usher 3
gene encodes clarin1, which has been speculated to func-
tion in synaptic shaping and maintenance, based on loose
homology with a protein known to function in this manner
in the cerebellum (Adato et al., 2002).
It has been proposed that many of the proteins might
function together in a common cellular mechanism. Such
a unifying hypothesis is attractive, and, certainly, the sim-
ilarities of clinical phenotype within the diﬀerent types of
Usher syndrome suggest that the mutated genes of each
type might aﬀect a common cellular mechanism. Experi-
mental evidence to support this notion has come from stud-
ies indicating that some of the Usher 1 proteins can interact
with each other.
In the ﬁrst studies to test protein binding among Usher
proteins, two groups found binding of the cytoplasmic
region of the ear-speciﬁc isoform of cadherin23 to the sec-
ond PDZ domain of harmonin (Boeda et al., 2002; Siemens
et al., 2002). One of the groups also reported binding
between the ﬁrst PDZ domain (PDZ1) of harmonin and
myosin VIIa (Boeda et al., 2002), while the other group
reported that the PDZ1 domain of harmonin binds the iso-
form of cadherin23 that is found in tissues other than the
ear, such as kidney, brain and retina (Siemens et al.,
2002). Subsequent binding studies linked more of the
Usher proteins together, with harmonin playing a central
role in the network (Weil et al., 2003). In the cochlear hair
cells, these binding studies have been supported by mutant
phenotypes, exhibiting defects in stereociliary development
and organization. Myosin VIIa and protocadherin15 have
thus been shown to bind each other and interact function-
ally in the cochlear hair cells (Senften et al., 2006).
The extent of interactions among Usher proteins in the
retina is less clear. Protein interaction in vitro is not neces-
sarily relevant in the physiological environment of an intact
tissue. It has been proposed that all the Usher 1 and Usher
2 proteins (including NBC3, which was considered previ-
ously, but is no longer a candidate for an Usher 2 protein)
436 D.S. Williams / Vision Research 48 (2008) 433–441form a large complex in the photoreceptor synapse (Kre-
mer, van Wijk, Marker, Wolfrum, & Roepman, 2006;
Reiners et al., 2003, 2005b; Reiners, Marker, Jurgens, Rei-
del, & Wolfrum, 2005a; Reiners, Nagel-Wolfrum, Jurgens,
Marker, & Wolfrum, 2006; Reiners & Wolfrum, 2006; van
Wijk et al., 2006). A weakness of this proposal is the lack of
solid evidence that most of these proteins actually reside in
the synaptic region. Immunoﬂuorescence images have been
presented to demonstrate localization in the photoreceptor
synaptic layer of the retina (Kremer et al., 2006; Reiners
et al., 2003, 2005a,b, 2006; Reiners & Wolfrum, 2006;
van Wijk et al., 2006), however, this localization is not con-
sistent with that reported by other groups (e.g. Gibbs &
Williams, 2004; Lillo, Siemens, Kazmierczak, Mueller, &
Williams, 2005; Liu et al., 2007). Nor is it supported by ret-
inal phenotypes of mutant mice.Fig. 1. Diagram of a photoreceptor and RPE cell. The region of the conne
indicating where myosin VIIa has been detected by immunogold labeling (Liu e
along the periciliary membrane has now been reported (Goodyear & Richard
et al., 2007; Yang et al., 2006). Modiﬁed from Williams 2002.None of the Usher mouse models has a mutant pheno-
type that could be attributed to photoreceptor synaptic
function. The ultrastructure and physiology of the synapses
appear normal. Shaker1, waltzer, Ames waltzer, whirler
and usherin knockout mice have all been shown to have
normal a-wave to b-wave ratios in their electroretinograms
(Haywood-Watson et al., 2006; Libby & Steel, 2001; Libby
et al., 2003; Liu et al., 2007; Sun et al., 2006), indicating
that the photoreceptor cell response (a-wave) is passed on
faithfully to the rest of the retina (which generates the b-
wave).
The one location where a number of Usher proteins
appear to be found together is in the ciliary and periciliary
region of the photoreceptor cells (Fig. 1). While some of
the Usher proteins might thus interact in this region, it is
noteworthy that this is the one region in the photoreceptorcting cilium and pericilium is enlarged on the right, with the black dots
t al., 1997a). Evidence of the presence of a number of other Usher proteins
son, 1999; Liu et al., 2007; McGee et al., 2006; Sun et al., 2006; Wolfrum
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Lillo et al., 2005; Reiners et al., 2003). Harmonin has been
presented as the central scaﬀold of Usher protein networks
in the inner ear and in the photoreceptor synapse, so that a
network in the ciliary and periciliary region of the photore-
ceptor cells would require a diﬀerent organization. Sans,
usherin and whirlin all appear to have scaﬀolding proper-
ties and may thus play such a role.
The ﬁrst Usher protein to be localized in this ciliary
region was myosin VIIa (Liu, Vansant, Udovichenko,
Wolfrum, & Williams, 1997a). This localization was cor-
roborated by the identiﬁcation of a mutant phenotype—
abnormal accumulation of opsin in the connecting cil-
ium—in studies of shaker1 mice (Liu et al., 1999). While
the emphasis on these earlier localization studies was on
the localization of myosin VIIa within the connecting cil-
ium, in retrospect, it is clear from published and unpub-
lished immunoelectron micrographs that the protein can
be also detected in the periciliary part of the inner segment
(see, for example, Figs. 12–14 in Liu et al., 1997a) (Fig. 1).
Full-length usherin has been localized to the periciliary
membrane (Liu et al., 2007), and this localization has been
reported to be dependent on the PDZ-domain protein,
whirlin (Liu et al., 2007; Yang et al., 2006), suggesting that
the Usher 1D protein is present here also. Abstracts report-
ing periciliary localization of protocadherin15 (Sun et al.,
2006) and sans (Wolfrum et al., 2007) have also been pre-
sented. Earlier, the ‘‘ankle link antigen’’, now identiﬁed
as VLGR1 (McGee et al., 2006), was detected in this region
(Goodyear & Richardson, 1999).
Hence, the connecting cilium region of the photorecep-
tor cells is a likely focus for Usher protein interaction
and function in the retina. Interestingly, the importance
of the photoreceptor cilium in retinal pathogenesis was
suggested some time ago as a result of Usher patient stud-
ies. Abnormal cilia were described in the photoreceptor
cells of postmortem Usher 2 retinas (Barrong et al., 1992;
Hunter, Fishman, Mehta, & Kretzer, 1986). Various
abnormalities that could be related to cilium defects in
other tissues of Usher patients were also reported. They
include impaired olfaction (Zrada, Braat, Doty, & Laties,
1996), decreased sperm motility (Hunter et al., 1986),
abnormal nasal cilia (Arden & Fox, 1979; Bonneau et al.,
1993), bronchitis (Bonneau et al., 1993), and asthma (Baris,
Ataman, Sener, & Kalyoncu, 1994). Consistent with a gen-
eral ciliary function, myosin VIIa was detected in cilia of a
variety of tissues (Wolfrum, Liu, Schmitt, Udovichenko, &
Williams, 1998).
Although more is known about the retinal function of
myosin VIIa than for any other Usher protein, its role in
the photoreceptor connecting cilium and periciliary region
is not clear. Lack of myosin VIIa causes an abnormal accu-
mulation of opsin in the connecting cilium, and a retarded
rate of the disk membrane renewal, thus indicating impair-
ment of delivery of opsin to the site of disk membrane mor-
phogenesis (Liu et al., 1999). Nevertheless, this defect is not
as severe as lack of heterotrimeric kinesin-2 function, fordeletion of this motor activity appears to completely block
the delivery of opsin to the outer segment, and cause rapid
photoreceptor cell death (Jimeno et al., 2006; Marszalek
et al., 2000). Hence, kinesin-2 appears more likely to pro-
vide motor transport of opsin along the connecting cilium.
Myosin VIIa could play an auxiliary role with kinesin-2,
consistent with a general theme in which a myosin provides
local transport in conjunction with longer-range transport
that is powered by a microtubule motor. Alternatively, its
eﬀect on opsin transport could be less direct, perhaps act-
ing through structural elements of the cilium and
pericilium.
In the ciliary region, myosin VIIa could interact with
other Usher proteins, given their colocalization, however,
by far the majority of retinal myosin VIIa is located in
the apical RPE (Hasson, Heintzelman, Santos-Sacchi,
Corey, & Mooseker, 1995), where it appears to be the only
Usher protein. Here, its roles include organelle transport,
most likely in concert with microtubule motors. A combi-
nation of in vivo studies and analyses of primary cultures
of RPE cells from mutant mice indicate that myosin VIIa
transports both phagosomes (Gibbs et al., 2003) and mela-
nosomes (Futter, Ramalho, Jaissle, Seeliger, & Seabra,
2004; Gibbs et al., 2004; Klomp, Teoﬁlo, Legacki, & Wil-
liams, 2007; Lopes et al., 2007). Phagosomes take longer
to travel to the basal RPE and are digested more slowly
in RPE cells lacking myosin VIIa (Gibbs et al., 2003). Live
cell imaging of melanosomes shows that melanosomes tra-
vel further and faster (at the speed of a microtubule motor)
in the absence of myosin VIIa, which moves melanosomes
at 200 nm/sec and appears to eﬀect their tethering in the
apical processes of the RPE (Gibbs et al., 2004; Klomp
et al., 2007; Lopes et al., 2007).
4. Prospects for retinal gene therapy for Usher syndrome
Gene therapy is a potential approach to prevent blind-
ness in Usher syndrome. Indeed, Usher syndrome is poten-
tially a highly suitable form of retinal degeneration for
treatment by gene therapy. First, all types appear to be
inherited recessively and caused by loss of gene function,
so that therapy need only focus on adding gene function.
Second, because of the associated impaired hearing at
birth, Usher syndrome patients can be more readily identi-
ﬁed prior to the onset of retinal degeneration. Nevertheless,
there are some drawbacks. Some of the Usher genes are
very large—USH2A and GPR98 encode retinal proteins
of 600–700 kDa (Liu et al., 2007; McMillan, Kayes-Wan-
dover, Richardson, & White, 2002) —making their delivery
problematic. Moreover, as noted above, there is presently a
paucity of mutant phenotypes that can be assayed to test
for eﬃcacy of treatment in animal models. When testing
gene therapy, it is important not only to monitor the
expression of the gene, but also to determine if the resulting
protein is functional.
Some types of Usher syndrome are therefore currently
not amenable to gene therapy. However, there has been
438 D.S. Williams / Vision Research 48 (2008) 433–441some progress with treatment for Usher 1B. MYO7A
cDNA has been delivered to retinas and cultured primary
RPE cells of Myo7a-null mice, using a lentiviral vector.
Using a promoter containing elements of the native
MYO7A promoter, appropriate levels of myosin VIIa were
obtained in the RPE cells, correction of mutant pheno-
types—melanosome motility and phagosome digestion in
cultured RPE cells, and melanosome localization and opsin
clearance from the connecting cilium in vivo—was
achieved (Hashimoto et al., 2007).
5. Concluding comment
Usher syndrome has turned out to be more genetically
complex than clinicians would have ﬁrst envisaged. Never-
theless, the identiﬁcation of the genes involved now
appears to be nearing completion. Understanding the reti-
nal roles of the Usher proteins represents a current major
challenge. A clearer picture of the localization, interactions
and functions of the Usher proteins in the retina will facil-
itate progress towards developing gene therapy prevention
of Usher blindness.
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